Insider · CIK 0001796310

Connealy Pamela Ann

Reports to the SEC for 3 companies · NEW HOPE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001796310

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-23	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.3K sh	—	—	21,277
2026-06-23	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+17.3K sh	—	—	66,038
2025-08-07	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+15K sh	—	—	48,711
2025-06-24	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+36.8K sh	—	—	36,797
2025-06-24	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+12.4K sh	—	—	33,711
2025-03-31	PYXSPyxis Oncology, Inc. · Stock Option (Right to Buy)A Award	CFO & COO	AAward	+414K sh	$0.98	+$406K	414,163
2024-12-23	PYXSPyxis Oncology, Inc. · Stock Option (Right to Buy)A Award	CFO & COO	AAward	+310K sh	—	—	310,000
2024-11-26	PYXSPyxis Oncology, Inc.P Purchase	CFO & COO	PPurchase	+5,450 sh	$2.00	+$10.9K	1,115,743
2024-11-26	PYXSPyxis Oncology, Inc.P Purchase	CFO & COO	PPurchase	+83.4K sh	$1.96	+$163K	1,199,143
2024-06-20	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+5,376 sh	—	—	21,289
2024-06-20	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.1K sh	—	—	17,068
2024-03-26	PYXSPyxis Oncology, Inc.A Award	CFO & COO	AAward	+329K sh	—	—	1,110,293
2023-11-29	PYXSPyxis Oncology, Inc.F Tax Payment	CFO & COO	FTax Payment	−36.9K sh	$1.40	−$51.7K	781,583
2023-09-28	PYXSPyxis Oncology, Inc.P Purchase	CFO & COO	PPurchase	+8,000 sh	$1.87	+$15K	818,532
2023-09-27	PYXSPyxis Oncology, Inc.P Purchase	CFO & COO	PPurchase	+6,426 sh	$1.85	+$11.9K	810,532
2023-09-25	PYXSPyxis Oncology, Inc.P Purchase	CFO & COO	PPurchase	+12K sh	$1.67	+$20K	804,106
2023-09-22	PYXSPyxis Oncology, Inc.P Purchase	CFO & COO	PPurchase	+5,000 sh	$1.74	+$8,695	792,106
2023-09-07	PYXSPyxis Oncology, Inc.A Award	CFO & COO	AAward	+188K sh	—	—	782,106
2023-07-20	OBIOOrchestra BioMed Holdings, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.5K sh	—	—	17,500
2023-07-20	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+11.7K sh	—	—	15,913
2023-04-12	OBIOOrchestra BioMed Holdings, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+758 sh	—	—	4,246
2023-04-12	OBIOOrchestra BioMed Holdings, Inc. · Right to Receive Earnout SharesM Exercise/Conversion	Director	MExercise/Conversion	−758 sh	—	—	758
2023-03-24	PYXSPyxis Oncology, Inc.A Award	CFO & COO	AAward	+210K sh	—	—	594,313
2023-03-24	PYXSPyxis Oncology, Inc. · Stock Option (Right to buy)A Award	CFO & COO	AAward	+10.3K sh	—	—	10,304
2023-03-24	PYXSPyxis Oncology, Inc. · Stock Option (Right to buy)A Award	CFO & COO	AAward	+322K sh	—	—	322,265
2023-03-24	PYXSPyxis Oncology, Inc. · Stock Option (Right to buy)D Disposition to Issuer	CFO & COO	DDisposition to Issuer	−10.3K sh	—	—	0
2023-03-24	PYXSPyxis Oncology, Inc. · Stock Option (Right to buy)D Disposition to Issuer	CFO & COO	DDisposition to Issuer	−322K sh	—	—	0
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+23.3K sh	—	—	23,250
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Right to Receive Earnout SharesA Award	Director	AAward	+1,516 sh	—	—	1,516
2023-01-26	OBIOOrchestra BioMed Holdings, Inc.A Award	Director	AAward	+3,488 sh	—	—	3,488
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+23.3K sh	—	—	23,250
2023-01-26	OBIOOrchestra BioMed Holdings, Inc. · Nonstatutory Stock Option (Right to Buy)A Award	Director	AAward	+18.6K sh	—	—	18,600
2023-01-03	PYXSPyxis Oncology, Inc.A Award	CFO & COO	AAward	+43.5K sh	—	—	384,510
2022-04-14	PYXSPyxis Oncology, Inc.A Award	CFO & COO	AAward	+93.5K sh	—	—	341,017
2022-03-31	PYXSPyxis Oncology, Inc.A Award	CFO & COO	AAward	+248K sh	—	—	247,524
2021-12-06	PYXSPyxis Oncology, Inc. · Stock Option (Right to buy)A Award	CFO & COO	AAward	+52.9K sh	—	—	52,944
2021-03-19	IMVTImmunovant, Inc.A Award	Chief Financial Officer	AAward	+46.2K sh	—	—	46,200
2021-03-19	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+162K sh	—	—	162,000
2020-05-15	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+181K sh	—	—	180,500
2019-12-18	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+434K sh	—	—	433,588

Recent filings

Accepted (ET)
Jun 254
Connealy Pamela Ann0001104659-26-077775
SEC(opens sec.gov)
Aug 84
Connealy Pamela Ann0001104659-25-075786
SEC(opens sec.gov)
Jun 264
Connealy Pamela Ann0001104659-25-063095
SEC(opens sec.gov)
Apr 24
Connealy Pamela Ann0000950170-25-048893
SEC(opens sec.gov)
Dec 234
Connealy Pamela Ann0000950170-24-139608
SEC(opens sec.gov)
Nov 274
Connealy Pamela Ann0000950170-24-131606
SEC(opens sec.gov)
Jun 214
Connealy Pamela Ann0001104659-24-074013
SEC(opens sec.gov)
Mar 284
Connealy Pamela Ann0000950170-24-038108
SEC(opens sec.gov)
Nov 304
Connealy Pamela Ann0001209191-23-056969
SEC(opens sec.gov)
Sep 284
Connealy Pamela Ann0001209191-23-050734
SEC(opens sec.gov)
Sep 274
Connealy Pamela Ann0001209191-23-050685
SEC(opens sec.gov)
Sep 254
Connealy Pamela Ann0001209191-23-050492
SEC(opens sec.gov)
Sep 224
Connealy Pamela Ann0001209191-23-050432
SEC(opens sec.gov)
Sep 84
Connealy Pamela Ann0001209191-23-048819
SEC(opens sec.gov)
Jul 244
Connealy Pamela Ann0001104659-23-083499
SEC(opens sec.gov)

Companies

Address

C/O ORCHESTRA BIOMED HOLDINGS, INC. 150 UNION SQUARE DRIVE

NEW HOPE, PA, 18938